Semi-Annual Statement Of Income And Retained Earnings

Modalis Therapeutics Corporation - Filing #7612938

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,291,208,000 JPY
-1,239,444,000 JPY
-425,465,000 JPY
-398,351,000 JPY
Non-operating income
Non-operating income
15,136,000 JPY
12,856,000 JPY
1,179,000 JPY
417,000 JPY
Non-operating expenses
Non-operating expenses
1,523,000 JPY
4,711,000 JPY
43,262,000 JPY
41,614,000 JPY
Ordinary profit (loss)
-1,277,595,000 JPY
-1,231,299,000 JPY
-467,548,000 JPY
-439,549,000 JPY
Extraordinary income
Extraordinary income
485,881,000 JPY
485,881,000 JPY
JPY
JPY
Profit (loss) before income taxes
-791,714,000 JPY
-745,417,000 JPY
-467,548,000 JPY
-439,549,000 JPY
Income taxes - current
1,333,000 JPY
1,333,000 JPY
1,210,000 JPY
1,210,000 JPY
Income taxes - deferred
-7,794,000 JPY
7,648,000 JPY
Profit (loss)
-793,047,000 JPY
-793,047,000 JPY
-793,047,000 JPY
-793,047,000 JPY
-738,956,000 JPY
-468,758,000 JPY
-448,407,000 JPY
-468,758,000 JPY
-468,758,000 JPY
-468,758,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.